Paloma Partners’s Immune Design Corp. IMDZ Stock Holding History

Paloma Partners’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-39,802	Closed	-$233K	–	2397
2019 Q1	$233K	Buy	+39,802	New	+$136K	0.01%	1440
2017 Q1	–	Sell	-11,510	Closed	-$63K	–	2448
2016 Q4	$63K	Buy	+11,510	New	+$81.3K	﹤0.01%	1922

Paloma Partners's IMDZ Position: Q2 2019 in Review

Paloma Partners sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 39,802 shares — an estimated $233K sold.

Paloma Partners first reported a position in IMDZ in Q4 2016 and held it in 2 quarters. The position peaked at $233K in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

Paloma Partners reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
Paloma Partners sold 39,802 Immune Design Corp. shares in Q2 2019, an estimated $233K.
Paloma Partners first reported a position in Immune Design Corp. in Q4 2016 and held it in 2 quarters.
Paloma Partners's Immune Design Corp. position peaked at $233K in Q1 2019.
0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on Paloma Partners's 13F filing for Q2 2019, filed 14 Aug 2019.